Price T Rowe Associates Inc. MD Has $324.47 Million Holdings in The Cooper Companies, Inc. (NASDAQ:COO)

Price T Rowe Associates Inc. MD grew its position in The Cooper Companies, Inc. (NASDAQ:COO - Free Report) by 517.0% during the 4th quarter, according to the company in its most recent disclosure with the SEC. The firm owned 3,529,477 shares of the medical device company's stock after purchasing an additional 2,957,421 shares during the period. Price T Rowe Associates Inc. MD owned about 1.77% of Cooper Companies worth $324,466,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds also recently made changes to their positions in the company. Tower Research Capital LLC TRC lifted its stake in Cooper Companies by 102.8% in the fourth quarter. Tower Research Capital LLC TRC now owns 13,489 shares of the medical device company's stock valued at $1,240,000 after buying an additional 6,838 shares in the last quarter. MML Investors Services LLC lifted its position in Cooper Companies by 3.5% in the 4th quarter. MML Investors Services LLC now owns 18,403 shares of the medical device company's stock valued at $1,692,000 after acquiring an additional 616 shares in the last quarter. Norinchukin Bank The boosted its stake in Cooper Companies by 9.4% in the 4th quarter. Norinchukin Bank The now owns 8,935 shares of the medical device company's stock worth $821,000 after purchasing an additional 766 shares during the period. Ossiam increased its holdings in Cooper Companies by 26.0% during the 4th quarter. Ossiam now owns 6,906 shares of the medical device company's stock worth $635,000 after purchasing an additional 1,427 shares in the last quarter. Finally, BI Asset Management Fondsmaeglerselskab A S raised its stake in shares of Cooper Companies by 1,628.6% in the 4th quarter. BI Asset Management Fondsmaeglerselskab A S now owns 278,052 shares of the medical device company's stock valued at $25,561,000 after purchasing an additional 261,967 shares during the period. Institutional investors and hedge funds own 24.39% of the company's stock.

Cooper Companies Stock Performance

COO traded up $0.38 during trading hours on Tuesday, reaching $82.23. The company's stock had a trading volume of 1,156,744 shares, compared to its average volume of 1,424,626. The company's 50-day moving average is $82.04 and its 200-day moving average is $92.41. The Cooper Companies, Inc. has a 52 week low of $69.81 and a 52 week high of $112.38. The firm has a market cap of $16.44 billion, a PE ratio of 42.17, a price-to-earnings-growth ratio of 2.25 and a beta of 1.01. The company has a debt-to-equity ratio of 0.32, a quick ratio of 1.12 and a current ratio of 1.91.

Cooper Companies (NASDAQ:COO - Get Free Report) last posted its earnings results on Thursday, March 6th. The medical device company reported $0.92 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.92. Cooper Companies had a net margin of 10.07% and a return on equity of 9.38%. The company had revenue of $964.70 million during the quarter, compared to analysts' expectations of $981.25 million. On average, equities analysts forecast that The Cooper Companies, Inc. will post 3.98 EPS for the current year.

Analyst Ratings Changes

A number of brokerages recently issued reports on COO. Citigroup dropped their target price on Cooper Companies from $115.00 to $110.00 and set a "buy" rating on the stock in a research report on Friday, March 7th. BNP Paribas upgraded shares of Cooper Companies to a "hold" rating in a report on Thursday, March 13th. Stifel Nicolaus lowered their price target on shares of Cooper Companies from $115.00 to $105.00 and set a "buy" rating on the stock in a research note on Friday, March 7th. Needham & Company LLC restated a "hold" rating on shares of Cooper Companies in a research note on Friday, March 7th. Finally, JPMorgan Chase & Co. lowered their target price on Cooper Companies from $120.00 to $110.00 and set an "overweight" rating on the stock in a research report on Friday, March 7th. Four analysts have rated the stock with a hold rating and seven have issued a buy rating to the company. Based on data from MarketBeat.com, the company has an average rating of "Moderate Buy" and a consensus target price of $110.25.

Cooper Companies Company Profile

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.